GlaxoSmithKline PLC (GSK) Social Stream
Glaxosmithkline Plc (GSK) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Glaxosmithkline Plc.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 8 | $52.5 | $41.5 | $47.75 | $43.7 | 9.27% |
| 2022-01-03 | 8 | $51 | $41.5 | $47.375 | $43.7 | 8.41% |
| 2022-01-17 | 7 | $51 | $44.2 | $48.733 | $43.7 | 11.52% |
| 2022-02-02 | 7 | $52.5 | $44.2 | $49.233 | $43.7 | 12.66% |
| 2022-02-14 | 7 | $52.5 | $46.3 | $49.933 | $43.7 | 14.26% |
| 2022-03-14 | 7 | $51.5 | $45.6 | $49.366 | $43.7 | 12.97% |
The Trend in the Analyst Price Target
GSK's average price target has moved up $1.99 over the prior 70 days.
Over the past 129 days, GSK's average upside potential has been 12.12%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-03 | 7 | 51.0 | 41.5 | 47.833 | 43.67 | 9.53% |
| 2022-01-17 | 7 | 51.0 | 44.2 | 48.733 | 45.47 | 7.18% |
| 2022-01-18 | 7 | 52.5 | 44.2 | 49.233 | 46.82 | 5.15% |
| 2022-02-14 | 7 | 52.5 | 46.3 | 49.933 | 42.87 | 16.48% |
| 2022-03-01 | 7 | 51.5 | 45.6 | 49.366 | 41.55 | 18.81% |
GSK Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.71 | 1 | 0 | 6 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 90 days, GSK's average broker recommendation rating improved by 0.04.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for GSK as an investment opportunity.
- GSK has a greater upside potential (average analyst target price relative to current price) than 44.72% of Pharmaceutical Products stocks.
- In terms of how Glaxosmithkline Plc fares relative to stocks in the large market cap category, note that its variance in analysts' estimates is lower than 23.13% of that group.
- Glaxosmithkline Plc's number of analysts covering the stock is greater than 123.71% of stocks in the large market cap category.
- To contextualize these metrics, consider that out of stocks in the large market cap category, Glaxosmithkline Plc's average analyst price target is higher than 178.09% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Glaxosmithkline Plc are GRFS, GMAB, and GLPG.
What is the outlook for GSK? Use POWR Ratings for clearer insight into price direction.